As Part of a Broad Effort to Invigorate Its Pipeline

As part of a broad effort to invigorate its pipeline and move more aggressively into biotechnology, GoodDrugs Inc. plans to set up a new division dedicated to developing biotherapeutic drugs and research technologies. The company expects to pay $240 million for set up costs of its new division now and $12 million in operating costs each year for the next 13 years. The company estimates that the new division will be able to generate annual revenue of $84 million 8 years from now. What is the net present worth of this investment if the company's minimum attractive rate of return is 7% per year and the study period is 13 years? Assume there is no salvage value.